For BRCA-wt BC, a significantly longer median time to recurrence was observed (95.0 months, 95% CI (72.6–117.4) compared to BRCA2 patients, 65.0 months, 95% CI (48.1–81.9), and BRCA1 patients, 31.0 months, 95% CI (13.9–48.1), p = 0.002). This evidence concerns the gene BRCA1 and breast cancer.